You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ADVM-022

Showing 1 - 25 of 55
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neovascular Age-related Macular Degeneration Trial in United States (ADVM-022)

Recruiting
  • Neovascular Age-related Macular Degeneration
  • ADVM-022
  • Phoenix, Arizona
  • +4 more
Sep 8, 2022

Long-Term Follow-up Study of ADVM-022 in DME (INFINITY-EXT)

Enrolling by invitation
  • Diabetic Macular Edema
  • Diabetic Retinopathy
  • ADVM-022
  • Beverly Hills, California
  • +6 more
Nov 4, 2022

Wet Age-related Macular Degeneration, Neovascular Age-related Macular Degeneration Trial in United States (ADVM-022)

Active, not recruiting
  • Wet Age-related Macular Degeneration
  • Neovascular Age-related Macular Degeneration
  • ADVM-022
  • Bakersfield, California
  • +10 more
Mar 21, 2022

Long-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT]

Enrolling by invitation
  • Wet Age-related Macular Degeneration
  • Neovascular Age-related Macular Degeneration
  • ADVM-022
  • Bakersfield, California
  • +8 more
Dec 23, 2021

Diabetic Macular Edema, Diabetic Retinopathy Trial in Puerto Rico, United States (6E11 vg/eye of ADVM-022, 2E11 vg/eye of

Active, not recruiting
  • Diabetic Macular Edema
  • Diabetic Retinopathy
  • 6E11 vg/eye of ADVM-022
  • +2 more
  • Phoenix, Arizona
  • +13 more
Jan 10, 2022

Tumors Trial in Spain, United States (TSR-022, Nivolumab, TSR-042)

Recruiting
  • Neoplasms
  • Goodyear, Arizona
  • +71 more
Dec 9, 2022

Herpes Zoster Trial in Tartu (HZ/su vaccine)

Recruiting
  • Herpes Zoster
  • HZ/su vaccine
  • Elkridge, Maryland
  • +47 more
Jan 6, 2023

Advanced/Metastatic Solid Tumors Trial in Australia, China (ATG-022)

Not yet recruiting
  • Advanced/Metastatic Solid Tumors
  • Adelaide, Australia
  • +3 more
Jan 30, 2023

Alpha 1-Antitrypsin Deficiency Trial in Gainesville, Charleston (ADVM-043)

Completed
Has Results
  • Alpha 1-Antitrypsin Deficiency
  • ADVM-043
  • Gainesville, Florida
  • +1 more
Aug 3, 2022

Systemic Lupus Erythematosus Trial in China (ICP-022, Placebos)

Completed
  • Systemic Lupus Erythematosus
  • Bengbu, Anhui, China
  • +10 more
Nov 28, 2022

Cancer, Relapsed/Refractory Large B-cell Lymphoma (LBCL) Trial (Fludarabine (30 mg/m^2), Cyclophosphamide (500 mg/m^2), CRG-022

Not yet recruiting
  • Cancer
  • Relapsed/Refractory Large B-cell Lymphoma (LBCL)
  • Fludarabine (30 mg/m^2)
  • +2 more
  • (no location specified)
Jul 25, 2023

Mantle Cell Lymphoma Trial in China (ICP-022)

Active, not recruiting
  • Mantle Cell Lymphoma
  • Hefei, Anhui, China
  • +30 more
Jul 5, 2022

Microcystic Lymphatic Malformation Trial in United States (PTX-022)

Recruiting
  • Microcystic Lymphatic Malformation
  • Little Rock, Arkansas
  • +5 more
Feb 25, 2022

CLL/SLL Trial in China (ICP-022)

Active, not recruiting
  • CLL/SLL
  • Hefei, Anhui, China
  • +24 more
Jul 5, 2022

Pachyonychia Congenita Trial in United States (PTX-022)

Active, not recruiting
  • Pachyonychia Congenita
  • Phoenix, Arizona
  • +3 more
Dec 2, 2021

Pachyonychia Congenita Trial in New Brighton (PTX-022)

Recruiting
  • Pachyonychia Congenita
  • New Brighton, Minnesota
    Minnesota Clinical Study Center
Dec 1, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in China (ICP-022, Chlorambucil, Rituximab)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Bengbu, Anhui, China
  • +55 more
Mar 25, 2022

Melanoma Stage III, Melanoma Stage IV Trial in Washington, Boston, Pittsburgh (Dostarlimab (TSR-042) (singly), Dostarlimab

Recruiting
  • Melanoma Stage III
  • Melanoma Stage IV
  • Dostarlimab (TSR-042) (singly)
  • Dostarlimab (TSR-042) and TSR-022 (combination)
  • Washington, District of Columbia
  • +2 more
Feb 22, 2022

Tumors, Metastatic Cancer, Advanced Cancer Trial in United States (Niraparib, TSR-042, Carboplatin-Paclitaxel)

Active, not recruiting
Has Results
  • Neoplasms
  • +6 more
  • Scottsdale, Arizona
  • +7 more
Oct 31, 2022

Adult Primary Liver Cancer, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer Trial in

Recruiting
  • Adult Primary Liver Cancer
  • +2 more
  • TSR-022 and TSR-042
  • Honolulu, Hawaii
    University of Hawaii
Sep 22, 2021

Migraine Disorders Trial (Rizatriptan 5 mg, Rizatriptan 10 mg, Standard Care)

Completed
Has Results
  • Migraine Disorders
  • Rizatriptan 5 mg
  • +2 more
  • (no location specified)
Feb 1, 2022

Migraine Headache Trial (rizatriptan benzoate (MK0462), Comparator: )

Completed
Has Results
  • Migraine Headache
  • rizatriptan benzoate (MK0462)
  • Comparator: placebo
  • (no location specified)
Feb 1, 2022

Sickle Cell Disease Trial (open-label GBT021601)

Not yet recruiting
  • Sickle Cell Disease
  • open-label GBT021601
  • (no location specified)
Nov 21, 2022

PCNSL, Secondary CNS Lymphoma Trial in Beijing, Guangzhou, Shanghai (ICP-022)

Recruiting
  • PCNSL
  • Secondary Central Nervous System Lymphoma
  • Beijing, Beijing, China
  • +4 more
Jul 28, 2021

Part 1:r/r B-cell Malignancies, Part 2:B-cell Malignancies Trial in United States (Orelabrutinib (ICP-022))

Recruiting
  • Part 1：r/r B-cell Malignancies
  • Part 2：B-cell Malignancies
  • Orelabrutinib (ICP-022)
  • Phoenix, Arizona
  • +26 more
Dec 7, 2021